| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1996;111:469-477
© 1996 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Brussels, Belgium
Received for publication Jan. 16, 1995. Accepted for publication April 26, 1995. Address for reprints: Jean-Louis LeClerc, MD, Department of Cardiac Surgery, University Hospital Erasme, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium.
Abstract
Cardiac surgery with cardiopulmonary bypass triggers an inflammatory response involving proinflammatory cytokines such as tumor necrosis factor-
, interleukin-6, and interleukin-8. To elucidate the pathophysiology of this cytokine response, we explored the possible differences in cytokine responses between patients undergoing heart transplantation and those undergoing coronary artery bypass grafting. Plasma levels of tumor necrosis factor-, interleukin-6, interleukin-8, and interleukin-10 were measured in eight patients undergoing heart transplantation (mean age 44 years) and eight patients undergoing coronary artery bypass grafting (mean age 61 years). Duration of cardiopulmonary bypass and ischemic time were both longer in the heart transplantation group than in the coronary artery bypass grafting group (133 ± 26 min vs 100 ± 31 min, p < 0.05, and 130 ± 47 min vs 58 ± 21 min, p < 0.005, respectively). Samples were collected before heparin administration, at aortic crossclamping and declamping, and at 0.5, 1, 1.5, 2, 4, 12, and 24 hours after declamping. Tumor necrosis factor-levels were significantly higher 30 minutes after aortic declamping in the heart transplantation group than in the coronary artery bypass grafting group (68 ± 30 vs 18 ± 5 pg/ml, p < 0.05). Interleukin-6 and interleukin-8 levels were also significantly higher 90 minutes after declamping in patients undergoing heart transplantation than in those undergoing coronary artery bypass grafting (310 ± 63 vs 169 ± 24 pg/ml, p < 0.05, and 73 ± 17 vs 24 ± 5 pg/ml, p < 0.01, respectively). Furthermore, interleukin-6 and interleukin-8 values 90 minutes after declamping were significantly correlated with the ischemic time (r = 0.72 and r = 0.82, respectively, both p < 0.05). Interleukin-10 levels in both groups rose to reach a peak value of around 115 pg/ml 1 hour after declamping. Patients undergoing heart transplantation exhibited a second peak of tumor necrosis factor-, interleukin-8, and interleukin-10 levels 12 hours after declamping, probably related to the administration of rabbit antihuman thymocyte immunoglobulin (Thymoglobuline) 3 hours after declamping. Interleukin-6 levels decreased more significantly 12 and 24 hours after declamping in patients undergoing heart transplantation, probably related to methylprednisolone therapy. In conclusion, cardiopulmonary bypass is associated with the production of both proinflammatory and antiinflammatory cytokines. The production of proinflammatory cytokines in patients undergoing heart transplantation is higher than that in patients undergoing coronary artery bypass grafting, and this increase could be related to the longer duration of ischemia in the former group. The later course of cytokine levels after heart transplantation may be further influenced by immunosuppressive therapy. (J THORAC CARDIOVASC SURG 1996;111:469-77)
This article has been cited by other articles:
|
|
 |
|
  C. S.H. Ng, A. A. Arifi, S. Wan, A. M.H. Ho, I. Y.P. Wan, E. M.C. Wong, and A. P.C. Yim Ventilation During Cardiopulmonary Bypass: Impact on Cytokine Response and Cardiopulmonary Function Ann. Thorac. Surg., January 1, 2008; 85(1): 154 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mathur, M. Baz, E. D. Staples, M. Bonnell, J. M. Speckman, P. J. Hess Jr, C. T. Klodell, D. G. Knauf, L. L. Moldawer, and T. M. Beaver Cytokine profile after lung transplantation: correlation with allograft injury. Ann. Thorac. Surg., May 1, 2006; 81(5): 1844 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Langer, R. Schramm, M. Bauer, D. Tscholl, T. Kunihara, and H.-J. Schafers Cytokine Response to Pulmonary Thromboendarterectomy Chest, July 1, 2004; 126(1): 135 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Byrne, M. Leacche, S. Paul, T. Mihaljevic, J. D. Rawn, S. K. Shernan, G. H. Mudge, and L. W. Stevenson Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 327 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Philippidis, J.C. Mason, B.J. Evans, I. Nadra, K.M. Taylor, D.O. Haskard, and R.C. Landis Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery Circ. Res., January 9, 2004; 94(1): 119 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Biglioli, A. Cannata, F. Alamanni, M. Naliato, M. Porqueddu, M. Zanobini, E. Tremoli, and A. Parolari Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 260 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ascione, M. Caputo, and G. D. Angelini Off-pump coronary artery bypass grafting: not a flash in the pan Ann. Thorac. Surg., January 1, 2003; 75(1): 306 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wan and A. P. C. Yim Tai Ji: The law of inflammatory response J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1071 - 1073. [Full Text]
|
|
|
|
|
|
L. Kubala, M. Ciz, J. Vondracek, J. Cerny, P. Nemec, P. Studenik, H. Cizova, and A. Lojek Perioperative and postoperative course of cytokines and the metabolic activity of neutrophils in human cardiac operations and heart transplantation J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1122 - 1129. [Abstract] [Full Text]
|
|
|
|
|
|
J. Borgermann, I. Friedrich, S. Flohe, J. Spillner, M. Majetschak, O. Kuss, A. Sablotzki, T. Feldt, J. C. Reidemeister, and F. U. Schade Tumor necrosis factor-{alpha} production in whole blood after cardiopulmonary bypass: Downregulation caused by circulating cytokine-inhibitory activities J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 608 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M Smith, S. Lecour, and M. N Sack Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program Cardiovasc Res, August 15, 2002; 55(3): 474 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sablotzki, I. Friedrich, J. Muhling, M. G Dehne, J. Spillner, R. E Silber, and E. Czeslik The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions Perfusion, March 1, 2002; 17(2): 103 - 109. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Appachi and E. B. Mossad Inflammatory Mediators and S-100{beta} Protein Concentrations in Neonates and Infants With Congenital Heart Disease Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 256 - 261. [Abstract] [PDF]
|
|
|
|
 |
|
 D. A. Smith, S. D. Irving, J. Sheldon, D. Cole, and J. C. Kaski Serum Levels of the Antiinflammatory Cytokine Interleukin-10 Are Decreased in Patients With Unstable Angina Circulation, August 14, 2001; 104(7): 746 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Stetson, A. Perez-Verdia, W. Mazur, J. A. Farmer, M. M. Koerner, D. G. Weilbaecher, M. L. Entman, M. A. Quinones, G. P. Noon, and G. Torre-Amione Cardiac Hypertrophy After Transplantation Is Associated With Persistent Expression of Tumor Necrosis Factor-{alpha} Circulation, August 7, 2001; 104(6): 676 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. M. Mueller, H. T. Tevaearai, P. Ruchat, F. Stumpe, and L. K. von Segesser Did the introduction of a minimally invasive technique change the incidence of atrial fibrillation after single internal thoracic artery-left anterior descending artery grafting? J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 683 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Onoe, T. Magara, Y. Yamamoto, and T. Nojima Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery Perfusion, January 1, 2001; 16(1): 37 - 42. [Abstract] [PDF]
|
|
|
|
|
|
P. Massoudy, S. Zahler, B. F. Becker, S. L. Braun, A. Barankay, and H. Meisner Evidence for Inflammatory Responses of the Lungs During Coronary Artery Bypass Grafting With Cardiopulmonary Bypass Chest, January 1, 2001; 119(1): 31 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Marano, L. A. Garulacan, K. V. Laughlin, L. Igidbashian, C. Trace, S. M. Goldman, F. P. Sutter, G. A. Reichard Jr, and J. M. Mullin Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass Ann. Thorac. Surg., October 1, 2000; 70(4): 1313 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yang, B. Zingarelli, and C. Szabo Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury Circulation, March 7, 2000; 101(9): 1019 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Birdi, M. Caputo, M. Underwood, A.J. Bryan, and G.D. Angelini The effects of cardiopulmonary bypass temperature on inflammatory response following cardiopulmonary bypass Eur. J. Cardiothorac. Surg., November 1, 1999; 16(5): 540 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wan, J.-L. LeClerc, M. Antoine, J.-M. DeSmet, A. P.C. Yim, and J.-L. Vincent Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study Ann. Thorac. Surg., October 1, 1999; 68(4): 1230 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Struber, J. T. Cremer, B. Gohrbandt, C. Hagl, M. Jankowski, B. Volker, H. Ruckoldt, M. Martin, and A. Haverich Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass Ann. Thorac. Surg., October 1, 1999; 68(4): 1330 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wimmer-Greinecker, G. Matheis, S. Martens, G. Oremek, U. Abdel-Rahman, and A. Moritz Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences Eur. J. Cardiothorac. Surg., August 1, 1999; 16(2): 211 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wan, M. B. Izzat, T. W. Lee, I. Y.P. Wan, N. L.S. Tang, and A. P.C. Yim Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury Ann. Thorac. Surg., July 1, 1999; 68(1): 52 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Massoudy, S. Zahler, A. Barankay, B. F. Becker, J. A. Richter, and H. Meisner Sodium nitroprusside during coronary artery bypass grafting: evidence for an antiinflammatory action Ann. Thorac. Surg., April 1, 1999; 67(4): 1059 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Liebold, C. Keyl, and D. E. Birnbaum The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass Eur. J. Cardiothorac. Surg., March 1, 1999; 15(3): 340 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Fransen, J. G. Maessen, T. W.O. Elenbaas, E. E.H.L. van Aarnhem, and M. P. van Dieijen-Visser Increased preoperative C-reactive protein plasma levels as a risk factor for postoperative infections Ann. Thorac. Surg., January 1, 1999; 67(1): 134 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-L Van Laethem, R Eskinazi, H Louis, F Rickaert, P Robberecht, and J Deviere Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice Gut, September 1, 1998; 43(3): 408 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Hill, R. P. Diego BS, A. H. Stammers, S. M. Huffman, and R. Pohorecki Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Ann. Thorac. Surg., January 1, 1998; 65(1): 66 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Sablotzki, M Dehne, I Welters, T Menges, N Lehmann, G Gorlach, C Osmer, and G Hempelmann Alterations of the cytokine network in patients undergoing cardiopulmonary bypass Perfusion, December 1, 1997; 12(6): 393 - 403. [Abstract] [PDF]
|
|
|
|
|
|
L. P. Perrault, P. Menasche, J. Peynet, B. Faris, A. Bel, T. de Chaumaray, C. Gatecel, B. Touchot, G. Bloch, and J.-M. Moalic On-Pump, Beating-Heart Coronary Artery Operations in High-Risk Patients: An Acceptable Trade-off? Ann. Thorac. Surg., November 1, 1997; 64(5): 1368 - 1373. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ohata, Y. Sawa, K. Kadoba, T. Masai, H. Ichikawa, and H. Matsuda Effect of Cardiopulmonary Bypass Under Tepid Temperature on Inflammatory Reactions Ann. Thorac. Surg., July 1, 1997; 64(1): 124 - 128. [Abstract] [Full Text]
|
|
|
|
|
|
S. Wan, J.-L. LeClerc, and J.-L. Vincent Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac Transplantation Ann. Thorac. Surg., January 1, 1997; 63(1): 269 - 276. [Abstract] [Full Text]
|
|
|
|
|
|
M.-C. Seghaye Interleukin-10 concentration in children undergoing cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1127 - 1128. [Full Text]
|
|
|
|
|
|
S. Wan, J.-M. DeSmet, L. Barvais, M. Goldstein, J.-L. Vincent, and J.-L. LeClerc MYOCARDIUM IS A MAJOR SOURCE OF PROINFLAMMATORY CYTOKINES IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 806 - 811. [Abstract] [Full Text]
|
|
|
|
|
|
W. T. McBride and J. V. Booth Human cytokine responses to cardiac operations: Prebypass factors J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 560 - 561. [Full Text]
|
|
|
|
|
|
S. Wan, J.-L. LeClerc, J.-M. DeSmet, and J.-L. Vincent Human cytokine responses to cardiac operations: Prebypass factors J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 561 - 561. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
